Project/Area Number |
10470515
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Laboratory medicine
|
Research Institution | The University of Tokyo |
Principal Investigator |
SHIBATA Yoichi Dept. of Transfusion Medicine, The University of Tokyo, Professor, 医学部・附属病院, 教授 (30010474)
|
Co-Investigator(Kenkyū-buntansha) |
TAKAHASHI Koki Okinaka Memorial Center for Adult Disease Research, Researcher, 研究員 (50171484)
TSUNO Nelson Dept. of Transfusion Medicine, The University of Tokyo, Instructor, 医学部・附属病院, 助手 (50282637)
|
Project Period (FY) |
1998 – 1999
|
Project Status |
Completed (Fiscal Year 1999)
|
Budget Amount *help |
¥12,500,000 (Direct Cost: ¥12,500,000)
Fiscal Year 1999: ¥5,100,000 (Direct Cost: ¥5,100,000)
Fiscal Year 1998: ¥7,400,000 (Direct Cost: ¥7,400,000)
|
Keywords | Pletelet Allo-antigen / Platelet Allo-antibody / Platelet Transfusion / Neonatal Alloimmune Thrombocytopenia / 血小板(HPA) / 新生児血小板減少症紫斑病 / 血小板輸血不応答 |
Research Abstract |
Platelet alloantibodies play a important role in neonatal alloimmune thrombocytopenia HPA (human platelet antigens) are known to be involved in neonatal allo-immunethrombocytopenia (NAIT). For the detection of platelet antibodies, we developed MPHA (mixed passive hemagglutination) method for detecting anti-platelet antibodies. Using MPHA test, we screened 20,333 sera from pregnant women (28-30 weeks gestation) and obtained the following results. (1) Unexpectedly high prevalence of platelet antibodies in 198 sera (0.97%) The specificity of them were as follows, anti-HPA-5b 168 sera(82, 3%), anti-HPA-4b 27 sera(13, 6%) anti-HPA-6b 2 sera(1, 0%), anti-Nak-a 5 sera(2, 5%) anti-HPA-4b+anti-HPA-5b 1 serum(0, 5%). (2) Five cases of NAIT were due to anti-HPA-5b, two cases of NAIT were due to anti-HPA-4b, and one case was due to anti-HPA-4b and anti-HPA-5b. This is the first prospective study on neonatal alloimmune thrombocytemia.
|